samedan logo
 
 
spacer
home > events calendar > more about event
PHARMACEUTICAL INDUSTRY EVENTS CALENDAR

Pre-Filled Syringes & Injectable Drug Devices Europe

Highly Potent Active Pharmaceutical Ingredients (HPAPI)

16-17 January 2019
Copthorne Tara Hotel, London

SMi is proud to present their 11th annual European conference and exhibition, within the Pre-Filled Syringes series: Pre-Filled Syringes & Injectable Drug Devices Europe. The event will take place on the 16th-17th of January 2019, in London. 

The conference will offer a deep insight into key areas within the field, such as: new technologies and overcoming their hurdles to implementation; connectivity for devices; updates on drug development and the impact on device developments and new regulatory guidelines. Our line-up of expert speakers will enable delegates to learn from market leaders on best practices to overcome common industry hurdles.

Join us in January 2019 to network, benchmark and learn about developments at the forefront of the Pre-Filled Syringes and Injectable Drug Devices industry.

Chairs for 2019:

· James Mellman, Device Manager, Novartis

· Anil Busimi, Strategy and Innovation Global Product Manager, SCHOTT

Featured Speakers:

· Anil Busimi, Strategy and Innovation Global Product Manager, SCHOTT

· Cedric Gysel, Staff Device Engineer, Janssen

· Davide Mercadante, Sr Associate Quality Drug Devices, Biogen

· Elise Legendre, Head of Late stage PFS Development, Sanofi

· James Mellman, Device Manager, Novartis

· Joan Malmstrom, Principal Scientist, Novo Nordisk

· Justin Wright, Global Head of Innovation, Novartis

· Maggie Reiff, Associate Device Engineer, Pfizer

· Mathieu Rigollet, Senior PFS Engineer, Roche

· Michael Becker, Design Engineer, Boehringer Ingelheim

· Reinhard Scheller, Commercial ManagerCyclo Olefin Polymers - COP Europe, Zeon Europe GmbH

· Shota Arakawa, Researcher, Mitsubishi Gas Chemical Company

· Stephen Barat, Head of Pre-Clinical and Early Clinical Development, SCYNEXIS

· Steve Chamberlain, Device Engineering Manager, GSK

· Suraj Ramachandran, Director, Merck

· Vikas Jaitely, Senior Manager Pharmaceutical Sciences & CMC Regulatory Intelligence,Merck



Key Highlights this January:

  • Engage and interact with like-minded individuals through 5+ hours of dedicated networking time, within the conference programme
  • Gain insight from fellow field experts through our interactive programme structure and our fantastic delegation with representation from all aspects of the industry, as well as cross-industry thought leaders and decision makers
  • Discover new technologies being developed to circumvent common industry hurdles and discuss ways in which to overcome the barriers of implementation
  • Hear case studies about the streamlining of injectable device development – from development to market
  • Interact with regulatory bodies in order to glean insight into the most recent revisions to regulation and the best ways to integrate them into business practices
  • Learn about current drug development programmes which will have an imminent impact on the PFS and Injectable devices sector and discuss the influence which drug development has on device development
  • Discuss patient centricity and the impact of human factors on design processes

View the full agenda online: www.pre-filled-syringes.com/samwl

phone +44 (0)20 7827 6000
email events@smi-online.co.uk
web https://bit.ly/2QROsgw
email Copthorne Tara Hotel, London
 
Print this page
Send to a friend
   
spacer
Industry Events

INTERPHEX 2019

2-4 April 2019, Javits Center, New York

At INTERPHEX, find all of the State-of-the-Art Solutions you need to Cost Effectively Develop and Manufacture Product. INTERPHEX is a premier pharmaceutical, biotechnology, and medical device development and manufacturing event and sponsored by Parenteral Drug Association (PDA). Dedicated to Innovation, Technologies and Knowledge, the show focuses on the entire product development life cycle.
More info >>

Banner of DIA_Europe_Events_95 on Samedan Banner of Drug Delivery Partnership 2018_events_97 on Samedan

White Papers

The Role of the CRO in Effective Risk-Based Monitoring

Medpace

The clinical trial industry is evolving. In an effort to improve participant safety and data integrity, regulators are encouraging trial sponsors to transition from a focused on-site monitoring approach they have traditionally employed toward a risk-based approach that utilizes a combination of centralized and on-site monitoring techniques to ensure patient safety and data quality. The Risk-Based Monitoring (RBM) paradigm has many potential advantages over established monitoring practices including enhanced patient safety and data integrity, more efficient and effective protocol design, reduced costs, and the ability to strategically adjust oversight in keeping with changes in risk level.
More info >>


News and Press Releases

RSSL introduces same-day mycoplasma testing service in UK

Reading Scientific Services Ltd (RSSL), a leading provider of scientific and technical solutions to the global biopharmaceutical, pharmaceutical, and biopharmaceutical sectors, has introduced the United Kingdom’s first same-day mycoplasma testing service for manufacturers of biologic medicines.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement